title: Off-label use of new oral anticoagulants: a one-way ticket to nowhere.
authors.affiliation: From the Stroke Unit, Department of Neurology, Hospital Vall d'Hebron-Barcelona, Barcelona, Spain (C.A.M.); and Stroke Division, Beth Israel Deaconess Medical Center, Boston, MA (M.H.S.). cmolina@vhebron.net mselim@bidmc.harvard.edu.
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Molina
authors.affiliation: From the Stroke Unit, Department of Neurology, Hospital Vall d'Hebron-Barcelona, Barcelona, Spain (C.A.M.); and Stroke Division, Beth Israel Deaconess Medical Center, Boston, MA (M.H.S.). cmolina@vhebron.net mselim@bidmc.harvard.edu.
authors.forename: Magdy H
authors.initials: MH
authors.lastname: Selim
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D006801:Humans; D008297:Male; D056687:Off-Label Use / Q000592:standards*; D020521:Stroke / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants
keywords: prevention & control